DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Dysli C, Wolf S, Hatz K. et al.
Fluorescence lifetime imaging in Stargardt disease: potential marker for disease progression.
Invest Ophthalmol Vis Sci 2016;
57: 832-841
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.